Drug Pipeline

Platinum-based chemotherapy Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
3
Recruiting
5
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-01 NCT07618624 BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent… Phase 2 Enrolling by Invitation
Active Studies by Phase
Phase 2
3
Phase 1/2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06465329 A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other… Non-Small Cell Lung Cancer Recruiting
NCT07358689 Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor… NSCLC Not Yet Recruiting
NCT07618624 BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent… Recurrent Head and Neck Squamous Cell Carcinoma Enrolling by Invitation
Phase 1/2
NCT04486833 Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer… Carcinoma, Non-Small Cell Lung Recruiting
Phase 1
NCT05614102 A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose… Advanced Solid Tumors Active, Not Recruiting
Not specified
NCT05363319 An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult… Non-small Cell Lung Cancer Recruiting
Sponsors Running Platinum-based chemotherapy Trials
Regeneron Pharmaceuticals (2) Genprex, Inc. (1) Bayer (1) Tianjin Medical University Cancer Institute and Hospital (1) Sun Yat-sen University (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (3) Lung Cancer (2) Head & Neck Cancer (1)
Get alerts when Platinum-based chemotherapy trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free